Select from our A to Z index of CMI (Consumer Medicines Information) leaflets for both prescription and over-the-counter medicines. Available as HTML, PDF and large font PDF.
containing sodium tetradecyl sulphate
Consumer Medicine Information
Please read this leaflet carefully. It contains important information about your treatment. If you have any doubts or questions, or if you are not sure about anything, ask your doctor or pharmacist.
It is important that you follow the instructions before and after administration of FIBRO-VEIN. Look at the label on the pack and this leaflet for details.
The name of your medicine is FIBRO-VEIN. It comes in the form of a glass ampoules or glass vials containing a clear sterile solution. FIBRO-VEIN contains the active ingredient, sodium tetradecyl sulphate at either 3%, 1%, 0.5% or 0.2% strength. The solution also contains the inactive ingredients: benzyl alcohol, di-sodium hydrogen phosphate, potassium di-hydrogen phosphate and water.
FIBRO-VEIN 3%, 1% and 0.5% is packed as 5 x 2ml glass ampoules, with a different colour label for each strength. In addition FIBRO-VEIN 3% also comes in 10 x 5ml rubber packed glass vials. FIBRO-VEIN 0.2% is only packed as 10 x 5ml rubber capped glass vials.
FIBRO-VEIN contains sodium tetradecyl sulphate which is one of the group of medicines known as sclerosants.
The product licence holder is STD Pharmaceutical Products Limited, Hereford, HR4 0EL, UK and the manufacturer is CP Pharmaceuticals, at Wexham LL13 9UF, UK.
FIBRO-VEIN is used in a procedure called compression sclerotherapy in the treatment of varicose veins.
Before you start treatment:
If the answer is YES to any of these questions, tell your doctor before you are treated with FIBRO-VEIN.
You should inform medical staff that you expect to be treated with FIBRO-VEIN; for example if you go into hospital or see a dentist or doctor for another matter.
Because FIBRO-VEIN is administered by injection into the vein it is always administered by a medically competent person. The normal dose administered is up to 1ml. For the 3% strength, a maximum of 4 sites (total 4ml) should be treated and for 1%, 0.5% and 0.2% strengths a maximum of 10 sites (total 10ml) should be treated. It is not supplied for self administration.
To obtain a satisfactory result from your treatment you should follow the following instructions:
Tell medical staff that you have taken FIBRO-VEIN; for example, if you go into hospital or see a dentist or doctor.
FIBRO-VEIN can sometimes cause side-effects in some people. The most often reported side effects are:
If you get any of these, or any other unusual effects, it is very important that you tell your doctor before receiving any further treatment.
REMEMBER: This medicine is for you. Only your doctor can prescribe it for you.
FIBRO-VEIN is a trademark.
Date of leaflet: 21 August 1995
100307/3
Published by MIMS/myDr November 2006